{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:25:11Z","timestamp":1771237511864,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Multiple studies have shown an association between intussusception (IS) and receipt of monovalent or pentavalent rotavirus vaccine (RV) in the previous 21 days. Disease severity is an important consideration for risk-benefit evaluations of RV, but no studies have compared the severity of IS within 21 days of vaccination (vaccine-associated, VA) and later (not temporally-associated, VNA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We used active hospital-based surveillance in the Australian Paediatric Active Enhanced Disease Surveillance (PAEDS) network (July 2007 to February 2018) to identify infants \u22649 months of age meeting Brighton level 1 criteria for IS. We used five severity levels: (1) no surgery and length of stay (LOS) \u22641 day, (2) no surgery and LOS \u22652 days, (3) surgery, no bowel resection, (4) bowel resection, and (5) ICU admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 323 eligible cases, 87 (26.9%) were VA and 236 (73.1%) VNA. VA-IS cases (median 21 weeks; 24.1% \u226414 weeks) were significantly younger than VNA-IS cases (median 28 weeks, 7.2% \u226414 weeks). Cases 0\u2013\u226414 weeks of age were significantly more likely than cases \u226525 weeks to require bowel resection (relative risk ratio 4.6, 95% CI, 1.48\u201314.3). This effect was not associated with RV. After adjustment for age and sex, VA-IS was not significantly overrepresented in severity levels 2\u20135; adjusted RRR of 1.37 (95% CI: 0.61\u20133.11) for bowel resection in cases 0\u2013\u226414 weeks of age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>IS was uncommon but significantly more severe under 14 weeks of age. After adjustment for age and sex, IS severity was not related to RV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003521","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T19:02:27Z","timestamp":1648839747000},"page":"507-513","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Severity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007\u20132018"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5453-070X","authenticated-orcid":false,"given":"Meru","family":"Sheel","sequence":"first","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Westmead, New South Wales"},{"name":"The University of Sydney, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, Sydney, New South Wales"},{"name":"National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, Australian National University, Canberra, Australia"},{"name":"The University of Sydney School of Public Health, Faculty of Medicine and Health, Sydney, New South Wales"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Westmead, New South Wales"},{"name":"The University of Sydney, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, Sydney, New South Wales"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Macartney","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Westmead, New South Wales"},{"name":"The University of Sydney, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, Sydney, New South Wales"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Buttery","sequence":"additional","affiliation":[{"name":"Department of Infection and Immunity, Monash Children\u2019s Hospital, Monash Health, Melbourne, Victoria"},{"name":"Monash Centre of Health Research and Implementation, Department of Paediatrics, Monash University, Melbourne, Victoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Dinsmore","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Westmead, New South Wales"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Marshall","sequence":"additional","affiliation":[{"name":"Women\u2019s and Children\u2019s Health Network and Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Elliott","sequence":"additional","affiliation":[{"name":"The University of Sydney, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, Sydney, New South Wales"},{"name":"Australian Paediatric Surveillance Unit, Kids Research Institute, Sydney Children\u2019s Hospitals Network, Westmead, New South Wales"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kynaston","sequence":"additional","affiliation":[{"name":"Queensland Children\u2019s Hospital, Brisbane, Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[{"name":"Wesfarmer\u2019s Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia"},{"name":"Department of General Paediatrics, Perth Children\u2019s Hospital, Perth, Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chateau","sequence":"additional","affiliation":[{"name":"National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, Australian National University, Canberra, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Westmead, New South Wales"},{"name":"The University of Sydney, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, Sydney, New South Wales"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of PAEDS Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine.","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s National Immunization Program.","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/j.vaccine.2017.05.064","article-title":"Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies.","volume":"35","author":"Kassim","year":"2017","journal-title":"Vaccine"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1016\/j.vaccine.2013.05.037","article-title":"Rotavirus vaccines WHO position paper: January 2013 - Recommendations.","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.vaccine.2013.02.007","article-title":"Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.","volume":"31","author":"Hull","year":"2013","journal-title":"Vaccine"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1713909","article-title":"Evaluation of intussusception after monovalent rotavirus vaccination in Africa.","volume":"378","author":"Tate","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0189-6725.194665","article-title":"Childhood intussusception: Impact of delay in presentation in a developing country.","volume":"13","author":"Ogundoyin","year":"2016","journal-title":"Afr J Paediatr Surg"},{"key":"R11-20250615","first-page":"221","article-title":"Review of naturally occurring intussusception in young children in the WHO African region prior to the era of rotavirus vaccine utilization in the expanded programme of immunization.","volume":"63","author":"Mpabalwani","year":"2017","journal-title":"J Trop Pediatr"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2807\/1560-7917.ES.2017.22.50.17-00041","article-title":"A benefit-risk analysis of rotavirus vaccination, France, 2015.","volume":"22","author":"Lamrani","year":"2017","journal-title":"Euro Surveill"},{"key":"R13-20250615","doi-asserted-by":"crossref","DOI":"10.33321\/cdi.2019.43.5","article-title":"Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions.","volume":"43","author":"McRae","year":"2019","journal-title":"Commun Dis Intell (2018)"},{"key":"R14-20250615","article-title":"Severe and complicated varicella and associated genotypes 10 years after introduction of a one dose varicella vaccine program.","author":"Marshall","year":"2018","journal-title":"J Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.vaccine.2003.09.016","article-title":"Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.","volume":"22","author":"Bines","year":"2004","journal-title":"Vaccine"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in U.S. infants.","volume":"370","author":"Yih","year":"2014","journal-title":"N Engl J Med"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1016\/j.vaccine.2016.10.014","article-title":"The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation Ref. No: JVAC-D-16-01124.","volume":"34","author":"Stowe","year":"2016","journal-title":"Vaccine"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1753-6405.12297","article-title":"Intussusception in Australia: epidemiology prior to the introduction of rotavirus vaccine.","volume":"39","author":"Palupi-Baroto","year":"2015","journal-title":"Aust N Z J Public Health"},{"key":"R20-20250615","first-page":"1427","article-title":"Addition of history of intussusception as a contraindication for rotavirus vaccination.","volume":"60","year":"2011","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12098-016-2230-z","article-title":"Risk of Intussusception with Rotavirus Vaccine.","volume":"84","author":"Kalaiselvan","year":"2017","journal-title":"Indian J Pediatr"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1038\/s41598-018-29515-2","article-title":"Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji.","volume":"8","author":"Ratu","year":"2018","journal-title":"Sci Rep"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/infdis\/jix186","article-title":"Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea.","volume":"215","author":"Burnett","year":"2017","journal-title":"J Infect Dis"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years.","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5694\/mja12.10062","article-title":"Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program.","volume":"197","author":"Dey","year":"2012","journal-title":"Med J Aust"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jpids\/piu097","article-title":"Febrile seizures in the era of rotavirus vaccine.","volume":"5","author":"Sheridan","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1016\/S2214-109X(19)30412-7","article-title":"Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.","volume":"7","author":"Clark","year":"2019","journal-title":"Lancet Glob Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:00:26Z","timestamp":1750003226000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003521","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,6]]}}}